Navigation Links
Bioinspired and Nanoengineered Surfaces: Technologies, Applications and Global Markets
Date:6/27/2013

MERCIAL AUTOMOTIVE END USES FOR

NANOENGINEERED SURFACES 58

TABLE 19 GLOBAL MARKET PROJECTIONS FOR AUTOMOTIVE APPLICATIONS

THROUGH 2022 ($ MILLIONS) 60

TABLE 20 MAIN COMMERCIAL AEROSPACE AND MARINE END-USE APPLICATIONS

FOR NANOENGINEERED SURFACES TECHNOLOGIES 62

TABLE 21 POTENTIAL LONGER-TERM COMMERCIAL AEROSPACE, MARINE AND

MILITARY END USES FOR NANOENGINEERED SURFACES 65

TABLE 22 GLOBAL MARKET PROJECTION FOR AVIATION/AEROSPACE AND MARINE

APPLICATIONS, THROUGH 2022 ($ MILLIONS) 67

TABLE 23 MAIN COMMERCIAL ELECTRONICS END-USE APPLICATIONS FOR

NANOENGINEERED SURFACES TECHNOLOGIES 69

TABLE 24 POTENTIAL LONGER-TERM COMMERCIAL ELECTRONICS END USES FOR

NANOENGINEERED SURFACES 74

TABLE 25 GLOBAL MARKET PROJECTIONS FOR ELECTRONIC NES APPLICATIONS,

THROUGH 2022 ($ MILLIONS) 77

TABLE 26 MAIN COMMERCIAL ENERGY AND ENVIRONMENTAL END-USE

APPLICATIONS FOR NANOENGINEERED SURFACES TECHNOLOGIES 79

TABLE 27 POTENTIAL LONGER-TERM COMMERCIAL ENERGY MARKET END USES FOR

NANOENGINEERED SURFACES 84

TABLE 28 POTENTIAL LONGER-TERM COMMERCIAL ENVIRONMENTAL MARKET END

USES FOR NANOENGINEERED SURFACES 85

TABLE 29 GLOBAL MARKET PROJECTIONS FOR ENERGY AND ENVIRONMENTAL NES

APPLICATIONS, THROUGH 2022 ($ MILLIONS) 88

TABLE 30 MAIN COMMERCIAL MATERIALS MARKET END-USE APPLICATIONS FOR

NANOENGINEERED SURFACES TECHNOLOGIES 90

TABLE 31 POTENTIAL LONGER-TERM MATERIALS MARKET END-USE APPLICATIONS

FOR NANOENGINEERED SURFACES TECHNOLOGIES 94

TABLE 32 GLOBAL MARKET REVENUE PROJECTION FOR NES APPLICATIONS IN

BUILDING MATERIALS, THROUGH 2022 ($ MILLIONS) 97

TABLE 33 MAIN COMMERCIAL OPTICAL MARKET END-USE APPLICATIONS FOR

NANOENGINEERED SURFACES TECHNOLOGIES 99

TABLE 34 POTENTIAL LONGER-TERM COMMERCIAL OPTICAL MARKET END USES FOR

NANOENGINEERED SURFACES 103

TABLE 35 MARKET REVE
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology news :

1. Bioinspired fibers change color when stretched
2. ASU awarded $3 million to research solar energy technologies, launch energy Ph.D. program
3. NAPCO Security Technologies, Inc. to Demonstrate New Product Capabilities at 2013 ISC West Conference and Exhibition
4. DNA Sequencing: Emerging Technologies and Applications
5. Over 30 years of global soil moisture observations for climate applications
6. Synthetic diamond steps closer to next generation of high performance electrochemical applications
7. Service Credit Union Selects DigitalPersona to Secure Access to Network and Applications
8. BGI debuts new tool PDXomics for tumor xenograft research and applications
9. Wrinkled surfaces could have widespread applications
10. Breakthrough study opens door to broader biomedical applications for Raman spectroscopy
11. DigitalPersona Announces U.are.U Software Development Kit (SDK) for Android Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 2015 Cellecta, Inc., a U.S.-based provider ... and biomarker discovery, announced the release of its ... all human protein coding genes. CRISPR technology enables ... gene,s function. Cellecta,s new Human Whole Genome CRISPR ... so that researchers can investigate in a single ...
(Date:7/21/2015)... , July 21, 2015 Today, ZTE ... Already received as well as expected revenues in 2015 that relate ... FPC,s communicated revenue guidance of approximately 2,200 MSEK for 2015. ... is a leading smartphone manufacturer in China ... FPC1 02 5 for Axon , ...
(Date:7/13/2015)... Conn. , Jul. 13, 2015 NXT-ID, ... "Company"), a biometric authentication company focused on the ... has filed provisional patent 62/188684 for ... achieves another new convenient and secure method to ... new, innovative payment methods, introduced with its groundbreaking ...
Breaking Biology News(10 mins):CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4
... DNA sequencing technologies have enormous potential for the ... these new technologies, researchers are able to greatly ... key to applications including plant breeding and physiology. ... (or phylogenetic) relationships among different plant species have ...
... is most often linked to excessive food intake or not ... often result in failed weight loss or weight regain in ... encourage your cat to get more exercise? Researchers from ... maintain healthy body weight in cats, looked at a previously ...
... , UK British start-ups Straw Fuels and ... month in an award-scheme supported by the EU,s ... start-up AdFerTech took home the Climate-KIC Early Stage ... the 20.000 first stage of Climate-KIC,s pan-European start-up ...
Cached Biology News:Sequencing hundreds of nuclear genes in the sunflower family now possible 2Sequencing hundreds of nuclear genes in the sunflower family now possible 3Smaller meals more times per day may curb obesity in cats 2Smaller meals more times per day may curb obesity in cats 3Liquor converter, BBQ logs win €20K prizes at UK innovation showcase 2
(Date:7/30/2015)... July 30, 2015 HIGHLIGHTS:Q2 2015 ... 2014) , Reported sales were $697 million compared ... Sales grew organically by 8%, and changes in foreign ... increased sales by 1%. , By business unit, ... Applied and 11% in SAFC Commercial. , Reported ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... fluid applications and designed for continuous operation up to 1500 bar. The sanitary ... safety, efficiency, and preventing toxic contamination. , The Pony™ NS2006L homogenizer is an ...
(Date:7/29/2015)... -- According to a new market research report, ... (2015-2020), , published by Mordor Intelligence, the Global market is ... of 2020, with North America being ... the global market size. The Global market for Stem Cells ... the period of (2015-2020).      (Logo: http://photos.prnewswire.com/prnh/20150428/740799) , ...
(Date:7/29/2015)... 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ) today ... Financial Officer has resigned.  The Company has hired ... retired in December 2014, as full time interim CFO ... Andy Ashworth began his employment ... smooth transition.  Andy was the Company,s CFO from September ...
Breaking Biology Technology:Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 3BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3
... Cell Therapeutics, Inc.,(CTI) (Nasdaq and MTA: CTIC) ... including accrued interest, of its 2008 Convertible,Notes which ... cash payment of,approximately $11.0 million. The Company currently ... this last piece of current debt provides the ...
... #58177-320-04 & 58177-330-04 ... Lot Numbers listed below, ST. LOUIS, ... specific additional lots of morphine,sulfate 60 mg extended release tablets, and ... precaution, due to the,possible presence of oversized tablets. Oversized tablets may ...
... Alexion,Pharmaceuticals, Inc. (Nasdaq: ALXN ) today announced ... Officer of Alexion,Pharmaceuticals, will present at the William ... 9:10 a.m., local time (10:10 a.m., eastern) on,Thursday, ... Mr. Sinha,s remarks will be available live. You ...
Cached Biology Technology:Cell Therapeutics, Inc. Repays $11.0 million Balance of 2008 Convertible Debt 2ETHEX Corporation Voluntarily Recalls Specific Lots of 30 mg. and 60 mg. Morphine Sulfate Extended Release Tablets Due to the Potential for Oversized Tablets 2ETHEX Corporation Voluntarily Recalls Specific Lots of 30 mg. and 60 mg. Morphine Sulfate Extended Release Tablets Due to the Potential for Oversized Tablets 3ETHEX Corporation Voluntarily Recalls Specific Lots of 30 mg. and 60 mg. Morphine Sulfate Extended Release Tablets Due to the Potential for Oversized Tablets 4
BD IMag Anti-Mouse CD90.2 (Thy1.2) Particles-DM 2 x 109 cells...
...
...
... III) from E. coli is an endoribonuclease ... dsRNA fragments that have 2-base, 3'-overhangs. ... fragments of 12-15 bp. RNase III ... ribonucleotides as well as DuraScript™ RNA, produced ...
Biology Products: